News
First molnupiravir active pharmaceutical ingredient (API) prequalified
Molnupiravir (WHOAPI-451) manufactured by Divi’s Laboratories Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalif
First human insulins prequalified
The first human insulins have been prequalified by WHO: fast-acting human insulin 100 IU/ml and intermediate-acting human insulin 100 IU/ml from Novo Nordisk A/S.
First molnupiravir generic prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s isoniazid 300mg tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
1st Invitation to manufacturers of IVDs medical devices used for the qualitative detection of Mycobacterium tuberculosis complex DNA and mutations associated with drug-resistant tuberculosis to apply for WHO prequalification assessment as of 22 September
To support the global effort to end the TB epidemic, through the provision of guidance to interested United Nations (UN) and other agencies and WHO Member States in their procurement decisions,
Mylan’s misoprostol tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Desano’s dolutegravir/lamivudine/tenofovir tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Hetero’s praziquantel 600mg tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Strides' dolutegravir 50mg tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Universal’s pyrimethamine/sulfadoxine dispersible tablet prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Desano’s atazanavir/ritonavir tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: